FIBERCON- calcium polycarbophil tablet

Fibercon by

Drug Labeling and Warnings

Fibercon by is a Otc medication manufactured, distributed, or labeled by Foundation Consumer Brands. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each caplet)

Calcium polycarbophil 625 mg equivalent to 500 mg polycarbophil

Purpose

Bulk-forming laxative

Uses

• relieves occasional constipation (irregularity)
• this product generally produces bowel movement in 12 to 72 hours

Warnings

Choking

Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

Ask a doctor before use if you have

• abdominal pain, nausea, or vomiting
• a sudden change in bowel habits that lasts over a period of 2 weeks

Ask a doctor or pharmacist before use if you aretaking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work.

When using this productdo not use for more than 7 days unless directed by a doctor

Stop use and ask a doctor ifrectal bleeding occurs or if you fail to have a bowel movement after use of this or any other laxative. These could be signs of a serious condition.

Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• take each dose of this product with at least 8 ounces (a full glass) of water or other fluid. Taking this product without enough liquid may cause choking. See chokingwarning.
• FiberCon works naturally so continued use for one to three days is normally required to provide full benefit. Dosage may vary according to diet, exercise, previous laxative use or severity of constipation.
• adults and children 12 years of age and over: 2 caplets per dose. Do not take more than 8 caplets in 24 hours unless directed by a doctor.
• children under 12 years of age: ask a doctor

Other information

• each caplet contains:140 mg calcium and 10 mg magnesium
• protect contents from moisture
• store at 20-25°C (68-77°F)

Inactive ingredients

caramel, crospovidone, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil, polyethylene glycol, silicon dioxide, sodium lauryl sulfate, stearic acid, talc

Questions or comments?

Call 1-888-594-0677weekdays 9 AM to 5 PM EST

SPL UNCLASSIFIED SECTION

Distributed by: Foundation Consumer Brands, LLC
Pittsburgh, PA 15212

WARNING: Reproductive Harm - www.P65warnings.ca.gov

PRINCIPAL DISPLAY PANEL - 140 Caplet Bottle

NEW FORMULA

FiberCon ®

Calcium Polycarbophil
Bulk-Forming Laxative

Simple Relief for Constipation

• Won't cause gas or bloating
• As effective as fiber powders

140 Coated Caplets

INGREDIENTS AND APPEARANCE

FIBERCON 
calcium polycarbophil tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 80070-500
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
CALCIUM POLYCARBOPHIL (UNII: 8F049NKY49) (POLYCARBOPHIL - UNII:W25LM17A4W)	CALCIUM POLYCARBOPHIL	625 mg

Inactive Ingredients
Ingredient Name	Strength
TALC (UNII: 7SEV7J4R1U)
CARAMEL (UNII: T9D99G2B1R)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
CROSPOVIDONE (120 .MU.M) (UNII: 68401960MK)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
SODIUM LAURYL SULFATE (UNII: 368GB5141J)
MINERAL OIL (UNII: T5L8T28FGP)
STEARIC ACID (UNII: 4ELV7Z65AP)

Product Characteristics
Color	brown	Score	2 pieces
Shape	OVAL	Size	18mm
Flavor		Imprint Code	LL;F1
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 80070-500-14	140 in 1 BOTTLE; Type 0: Not a Combination Product	04/04/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M007	04/04/2021

Labeler - Foundation Consumer Brands (117603632)